Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Weight-Loss Medication Improves Cholesterol

Posted: Thursday, February 16, 2006

F. Xavier Pi-Sunyer, M.D., of St. Luke's-Roosevelt Hospital Center at Columbia University College of Physicians and Surgeons in New York, and colleagues studied the effectiveness and safety of rimonabant for long-term weight management in obese and high-risk overweight patients.

Researchers found, compared with the placebo group, patients receiving 20 milligrams of rimonabant produced greater than average reductions in weight, waist circumference, and level of triglycerides. The patients on rimonabant also had a greater increase in their levels of high-density lipoprotein (HDL), or good cholesterol.

"It must be acknowledged that the trial was limited by a high dropout rate and that long-term effects of the drug require further study. Still, our observations collectively suggest that rimonabant may well represent an innovative approach to the management of multiple cardiometabolic risk factors, facilitating and maintaining improvements through weight loss," study authors say.

 

Source: Ivanhoe Newswire:

 
 
 
 
 
Join us on Facebook
 
 
 

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement